SAMAR ALSAFADI

Samar Alsafadi is a pharmacist and PhD scientist specialized in cancer biology and therapies. She manages the Uveal Melanoma Translational group aiming to accelerate the research on uveal melanoma, a rare tumor for which Curie Institute is a national reference center, and to reinforce the cooperation between clinicians and scientists. The group benefits from several national and international collaborations with research groups, healthcare centers and pharmaceutical actors. Her research focuses on different translational aspects including: 1) the identification of druggable oncogenic factors; 2) the development of in vitro and in vivo relevant preclinical models; 3) the pre-clinical evaluation of new therapeutic strategies and drug combinations.